Cite Filings / FHTX / 0001562180-22-006641

Feed Companies Filings Check

Sign in

3/A

Filing

Foghorn Therapeutics Inc. Filed 2022-09-13 Acc 0001562180-22-006641

Documents 1

3/A , xslF345X02/primarydocument.xml

Around this filing

2022-09-19 4 Chief Executive Officer acquired 40,000 shares (option exercise)
2022-09-14 4 Director acquired 82,000 shares (option exercise)
2022-09-13 3/A 3/A
2022-09-09 3/A 3/A
2022-09-09 3/A 3/A
2022-09-09 3/A 3/A

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslF345X02/primarydocument.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…